Literature DB >> 20692003

Risk model of in-hospital mortality after pulmonary resection for cancer: a national database of the French Society of Thoracic and Cardiovascular Surgery (Epithor).

Alain Bernard1, Caroline Rivera, Pierre Benoit Pages, Pierre Emmanuel Falcoz, Eric Vicaut, Marcel Dahan.   

Abstract

OBJECTIVES: The estimation of risk-adjusted in-hospital mortality is essential to allow each thoracic surgery team to be compared with national benchmarks. The objective of this study is to develop and validate a risk model of mortality after pulmonary resection.
METHODS: A total of 18,049 lung resections for non-small cell lung cancer were entered into the French national database Epithor. The primary outcome was in-hospital mortality. Two independent analyses were performed with comorbidity variables. The first analysis included variables as independent predictive binary comorbidities (model 1). The second analysis included the number of comorbidities per patient (model 2).
RESULTS: In model 1 predictors for mortality were age, sex, American Society of Anesthesiologists score, performance status, forced expiratory volume (as a percentage), body mass index (in kilograms per meter squared), side, type of lung resection,extended resection, stage, chronic bronchitis, cardiac arrhythmia, coronary artery disease, congestive heart failure, alcoholism, history of malignant disease, and prior thoracic surgery. In model 2 predictors were age, sex, American Society of Anesthesiologists score, performance status, forced expiratory volume, body mass index, side, type of lung resection, extended resection, stage, and number of comorbidities per patient. Models 1 and 2 were well calibrated, with a slope correction factor of 0.96 and of 0.972, respectively. The area under the receiver operating characteristic curve was 0.784 (95% confidence interval, 0.76-0.8) in model 1 and 0.78 (95% confidence interval, 0.76-0.797) in model 2.
CONCLUSIONS: Our preference is for the well-calibrated model 2 because it is easier to use in practice to estimate the adjusted postoperative mortality of lung resections for cancer. Copyright Â
© 2011 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20692003     DOI: 10.1016/j.jtcvs.2010.06.044

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  15 in total

1.  eComment. Re: Accuracy of two scoring systems for risk stratification in thoracic surgery.

Authors:  Gaetano Rocco
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-05

2.  Worse Prognosis for Stage IA Lung Cancer Patients with Smoking History and More Severe Chronic Obstructive Pulmonary Disease.

Authors:  Yukihiro Yoshida; Hidenori Kage; Tomohiro Murakawa; Yasunori Sato; Satoshi Ota; Masashi Fukayama; Jun Nakajima
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-01-26       Impact factor: 1.520

3.  Surgical risk models: how they contribute to improvement of our treatments?

Authors:  Janusz R Włodarczyk; Jarosław Kużdżał
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

4.  The impact of decreasing cutoff values for maximal oxygen consumption (VO(2)max) in the decision-making process for candidates to lung cancer surgery.

Authors:  Gaetano Rocco; Tindaro Gatani; Massimo Di Maio; Ilernando Meoli; Antonello La Rocca; Nicola Martucci; Carmine La Manna; Francesco Stefanelli
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

5.  Management and postoperative outcome in primary lung cancer and heart disease co-morbidity: a systematic review and meta-analysis.

Authors:  George D Bablekos; Antonis Analitis; Stylianos A Michaelides; Konstantinos A Charalabopoulos; Anastasia Tzonou
Journal:  Ann Transl Med       Date:  2016-06

6.  Unhealthy alcohol use is associated with postoperative complications in veterans undergoing lung resection.

Authors:  Solomon A Graf; Steven B Zeliadt; Peter J Rise; Leah M Backhus; Xiao-Hua Zhou; Emily C Williams
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

7.  Does age over 80 years have to be a contraindication for lung cancer surgery-a nationwide database study.

Authors:  Pierre-Benoit Pagès; Anne-Sophie Mariet; Arnaud Pforr; Jonathan Cottenet; Leslie Madelaine; Halim Abou-Hanna; Alain Bernard; Catherine Quantin
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

8.  A systematic review of risk prediction models for perioperative mortality after thoracic surgery.

Authors:  Marcus Taylor; Syed F Hashmi; Glen P Martin; Michael Shackcloth; Rajesh Shah; Richard Booton; Stuart W Grant
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-04-08

9.  Recent Trends in Demographics, Surgery, and Prognosis of Patients with Surgically Resected Lung Cancer in a Single Institution from Korea.

Authors:  Jae Kwang Yun; Han Pil Lee; Geun Dong Lee; Hyeong Ryul Kim; Yong Hee Kim; Dong Kwan Kim; Seung Il Park; Sehoon Choi
Journal:  J Korean Med Sci       Date:  2019-11-25       Impact factor: 2.153

10.  Video-assisted thoracoscopic lobectomy is feasible for selected patients with clinical N2 non-small cell lung cancer.

Authors:  Jae Kwang Yun; Geun Dong Lee; Sehoon Choi; Hyeong Ryul Kim; Yong-Hee Kim; Seung-Il Park; Dong Kwan Kim
Journal:  Sci Rep       Date:  2020-09-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.